CellaVision AB (publ) (STO:CEVI)
Sweden · Delayed Price · Currency is SEK 162.80
-1.60 (-0.97%)
Oct 15, 2026, 3:28 PM CET
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 3.88 billion as of October 15, 2026. It is the 16,425th most valuable company in the world and the 201st biggest in Sweden. Its market cap has decreased by 10.06% in one year.
Market Cap
3.88B
Enterprise Value
3.76B
Revenue
739.15M
Global Rank
Country Rank
#201 Sweden
PE Ratio
30.38
ChartMarket Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 3.88B, an increase of 943.57%. That is a compound annual growth rate of 12.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 3.88B | 3.56% |
| Dec 30, 2025 | 3.75B | -27.72% |
| Dec 30, 2024 | 5.19B | 2.59% |
| Dec 29, 2023 | 5.06B | -7.42% |
| Dec 30, 2022 | 5.46B | -29.58% |
| Dec 30, 2021 | 7.76B | 5.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elekta AB | 22.00B |
| Nolato AB | 15.30B |
| Vitrolife AB | 13.35B |
| MedCap AB | 7.90B |
| Xvivo Perfusion AB | 6.84B |
| BICO Group AB | 1.76B |
| Paxman AB | 1.51B |
| C-Rad AB | 965.73M |